Catalyst Pharmaceuticals (CPRX) Other Non-Current Assets (2010 - 2022)
Catalyst Pharmaceuticals posted quarterly Other Non-Current Assets of $9000.0 for Q4 2022, little changed year-on-year from $9000.0 in Q4 2021, and little changed on a QoQ basis from $9000.0 in Q3 2022.
Catalyst Pharmaceuticals (CPRX) has 13 years of Other Non-Current Assets data on file, last reported at $9000.0 in Q4 2022.
- For the quarter ending Q4 2022, Other Non-Current Assets changed 0.0% year-over-year to $9000.0; the trailing twelve-month figure through Dec 2022 stood at $9000.0 (changed 0.0% YoY), and the FY2022 full-year result was $9000.0, changed 0.0% from the prior year.
- Other Non-Current Assets for Q4 2022 stood at $9000.0, roughly flat from $9000.0 in the prior quarter.
- Across five years, Other Non-Current Assets topped out at $9000.0 in Q4 2020 and bottomed at $8888.0 in Q1 2018.
- The 5-year median for Other Non-Current Assets is $8888.0 (2018), against an average of $8938.4.
- The widest annual swing landed in 2018, when Other Non-Current Assets changed 0.0%; it then climbed 1.26% in 2020.
- A 5-year view of Other Non-Current Assets shows it stood at $8888.0 in 2018, then changed by 0.0% to $8888.0 in 2019, then grew by 1.26% to $9000.0 in 2020, then changed by 0.0% to $9000.0 in 2021, then changed by 0.0% to $9000.0 in 2022.
- The last three Other Non-Current Assets figures came in at $9000.0 (Q4 2022), $9000.0 (Q3 2022), and $9000.0 (Q2 2022), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 12.40 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 60,000.00 |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 1.26 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 2.13 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 63.55 Mn |
| 10 | Catalyst Pharmaceuticals | 3.82 Bn | 3.07 Bn | 134.92 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | 9,000.00 |
| Sep 30, 2022 | 9,000.00 |
| Jun 30, 2022 | 9,000.00 |
| Mar 31, 2022 | 9,000.00 |
| Dec 31, 2021 | 9,000.00 |
| Sep 30, 2021 | 9,000.00 |
| Jun 30, 2021 | 9,000.00 |
| Mar 31, 2021 | 9,000.00 |
| Dec 31, 2020 | 9,000.00 |
| Sep 30, 2020 | 8,888.00 |
| Jun 30, 2020 | 8,888.00 |
| Mar 31, 2020 | 8,888.00 |
| Dec 31, 2019 | 8,888.00 |
| Sep 30, 2019 | 8,888.00 |
| Jun 30, 2019 | 8,888.00 |
| Mar 31, 2019 | 8,888.00 |
| Dec 31, 2018 | 8,888.00 |
| Sep 30, 2018 | 8,888.00 |
| Jun 30, 2018 | 8,888.00 |
| Mar 31, 2018 | 8,888.00 |
| Dec 31, 2017 | 8,888.00 |
| Sep 30, 2017 | 8,888.00 |
| Jun 30, 2017 | 8,888.00 |
| Mar 31, 2017 | 8,888.00 |
| Dec 31, 2016 | 8,888.00 |
| Sep 30, 2016 | 8,888.00 |
| Jun 30, 2016 | 8,888.00 |
| Mar 31, 2016 | 8,888.00 |
| Dec 31, 2015 | 8,888.00 |
| Sep 30, 2015 | 8,888.00 |
| Jun 30, 2015 | 8,888.00 |
| Mar 31, 2015 | 8,888.00 |
| Dec 31, 2014 | 8,888.00 |
| Sep 30, 2014 | 8,888.00 |
| Jun 30, 2014 | 8,888.00 |
| Mar 31, 2014 | 8,888.00 |
| Dec 31, 2013 | 8,888.00 |
| Sep 30, 2013 | 8,888.00 |
| Jun 30, 2013 | 8,888.00 |
| Dec 31, 2012 | 8,888.00 |
| Mar 31, 2012 | 8,888.00 |
| Dec 31, 2011 | 8,888.00 |
| Sep 30, 2011 | 10,511.00 |
| Jun 30, 2011 | 10,511.00 |
| Dec 31, 2010 | 10,511.00 |